Found: 68
Select item for more details and to access through your institution.
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2014, v. 14, n. 2, p. 132, doi. 10.1016/j.clbc.2013.10.010
- By:
- Publication type:
- Article
Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2014, v. 14, n. 2, p. 94, doi. 10.1016/j.clbc.2013.10.013
- By:
- Publication type:
- Article
Beyond Palliative Mastectomy in Inflammatory Breast Cancer—A Reassessment of Margin Status.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 1999, v. 6, n. 3, p. 249, doi. 10.1007/s10434-999-0249-3
- By:
- Publication type:
- Article
Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 615, doi. 10.1007/s10549-018-05104-9
- By:
- Publication type:
- Article
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 2, p. 363, doi. 10.1007/s10549-018-4911-y
- By:
- Publication type:
- Article
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 3, p. 499, doi. 10.1007/s10549-018-4779-x
- By:
- Publication type:
- Article
Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients.
- Published in:
- Diagnostic Cytopathology, 1998, v. 19, n. 6, p. 417, doi. 10.1002/(SICI)1097-0339(199812)19:6<417::AID-DC3>3.0.CO;2-P
- By:
- Publication type:
- Article
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.
- Published in:
- Nature Medicine, 2010, v. 16, n. 12, p. 1421, doi. 10.1038/nm.2250
- By:
- Publication type:
- Article
Emerging Trends and Strategies in the Treatment of Breast Cancer.
- Published in:
- Journal of Managed Care Medicine, 2011, v. 14, n. 4, p. 56
- By:
- Publication type:
- Article
Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064338
- By:
- Publication type:
- Article
Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007220
- By:
- Publication type:
- Article
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 3013, doi. 10.1007/s00262-023-03470-y
- By:
- Publication type:
- Article
Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5000, doi. 10.3390/cancers14205000
- By:
- Publication type:
- Article
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4279, doi. 10.3390/cancers14174279
- By:
- Publication type:
- Article
Influence of Estrogen Treatment on ESR1 + and ESR1 − Cells in ER + Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6375, doi. 10.3390/cancers13246375
- By:
- Publication type:
- Article
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
- Published in:
- 1994
- By:
- Publication type:
- journal article
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 2, p. 469, doi. 10.1007/s10549-017-4516-x
- By:
- Publication type:
- Article
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 2, p. 297, doi. 10.1007/s10549-016-4006-6
- By:
- Publication type:
- Article
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 2, p. 351, doi. 10.1007/s10549-013-2797-2
- By:
- Publication type:
- Article
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 3, p. 759, doi. 10.1007/s10549-013-2572-4
- By:
- Publication type:
- Article
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 1, p. 155, doi. 10.1007/s10549-011-1508-0
- By:
- Publication type:
- Article
Papillary carcinoma of the breast: an overview.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 3, p. 637, doi. 10.1007/s10549-010-0961-5
- By:
- Publication type:
- Article
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 115, n. 1, p. 1, doi. 10.1007/s10549-008-0056-8
- By:
- Publication type:
- Article
Increased abdominal girth in a 29-year-old breast cancer patient with extensive liver metastasis and presumed chemotherapy induced amenorrhea. A case report and review of the literature.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 106, n. 3, p. 305, doi. 10.1007/s10549-007-9501-3
- By:
- Publication type:
- Article
Association of reactive oxygen species levels and radioresistance in cancer stem cells.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
- Published in:
- Nature Cell Biology, 2015, v. 17, n. 2, p. 183, doi. 10.1038/ncb3094
- By:
- Publication type:
- Article
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.
- Published in:
- Nature Cell Biology, 2014, v. 16, n. 12, p. 1238, doi. 10.1038/ncb3058
- By:
- Publication type:
- Article
An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 310, doi. 10.1016/j.clml.2012.08.003
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)–Positive Breast Cancer.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 4, p. e192561, doi. 10.1001/jamanetworkopen.2019.2561
- By:
- Publication type:
- Article
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 4, p. 14802, doi. 10.1038/ncomms14802
- By:
- Publication type:
- Article
Acute Lymphoblastic Leukemia (ALL) as a Second Primary Malignancy (SPM) After Multiple Myeloma (MM): Secondary Clonally Related Neoplasm or Therapy-Related Leukemia?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e29, doi. 10.1016/j.clml.2017.03.050
- By:
- Publication type:
- Article
Incidence and Timing of Graft Versus Host Disease (GVHD) After Daratumumab(Dara) Anti CD38 Therapy Post Allogeneic Transplant (alloHCT)for Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e71, doi. 10.1016/j.clml.2017.03.129
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 927, doi. 10.1007/s00280-010-1242-z
- By:
- Publication type:
- Article
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1149, doi. 10.1007/s00280-009-0977-x
- By:
- Publication type:
- Article
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 549, doi. 10.1007/s00280-006-0297-3
- By:
- Publication type:
- Article
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 4, p. 283, doi. 10.1007/s00280-004-0818-x
- By:
- Publication type:
- Article
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 3, p. 241, doi. 10.1007/s00280-004-0803-4
- By:
- Publication type:
- Article
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 6, p. 459, doi. 10.1007/s00280-003-0605-0
- By:
- Publication type:
- Article
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 5, p. 403
- By:
- Publication type:
- Article
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
- Published in:
- Transfusion, 2007, v. 47, n. 12, p. 2207, doi. 10.1111/j.1537-2995.2007.01448.x
- By:
- Publication type:
- Article
Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An international oncology study group (IOSG) phase II protocol.
- Published in:
- American Journal of Hematology, 2000, v. 63, n. 3, p. 125, doi. 10.1002/(SICI)1096-8652(200003)63:3<125::AID-AJH3>3.0.CO;2-S
- By:
- Publication type:
- Article